*Donations are received by Cancer Research UK before being used to support the Crick’s purposes. You can support the Crick by donating to Cancer Research UK.
For this arrangement to be possible, Cancer Research UK and the Crick share information about donors and prospective donors with each other.
Tackling COVID-19 at the Francis Crick Institute
We have partnered with UCLH to deliver a large-scale coronavirus vaccination centre at the Crick in our public gallery space. We also rapidly repurposed our lab space at the start of the pandemic, to set up a coronavirus testing facility in a matter of weeks. Our testing service helps ten local hospitals and 150 care homes to remain open and safe for staff and patients. It has also allowed us to safely continue vital research.
Crick group leader Adrian Hayday is leading a team from the Crick, King's College London and Guy's and St Thomas's Hospital. The multidisciplinary team are studying how patients' immune systems respond to the virus to understand why some people show no symptoms, while others have to be hospitalised and require critical care.
Clinical group leader Samra Turajlic is working with Royal Marsden NHS Foundation Trust to determine the impact of the pandemic on cancer patients, including how vaccination may affect people with cancer.
David LV Bauer, Rupert Beale, and Kate Bishop are co-project leads, as part of a national research project, to study the effects of emerging SARS-CoV-2 variants.
Paul Bates has joined forces with supercomputing firm Hadean to contribute to their mathematical models of virus transmission, tracking how viruses move within and between cities.
Steve Gamblin's group are using cryo-electron microscopy to study a structure on the surface of the virus, answering questions about how the virus interacts with our cells and how it made the leap from animals to humans. Steve’s work contributed critical understanding about the biology of the H1N1 virus strain that caused the 1918 Spanish Flu pandemic.